Details

DSEN Abstract: Assessing the potential for additive toxicity arising from the combined use of immune checkpoint inhibitors and of tyrosine kinase inhibitors - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Mar 18, 2026 · edition #8
Timestamp
2026-03-18T07:37:36.750Z
Language
en
Original URL
https://cihr-irsc.gc.ca/e/54101.html?wbdisable=false
Replay URL
https://replay.healtharchive.ca/job-8/20260318073736/https://cihr-irsc.gc.ca/e/54101.html?wbdisable=false#ha_snapshot=1201505
ID
1201505
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

ViewView diffRaw HTML ↗Metadata JSON ↗CiteReport issueAll snapshots

Other snapshots

Archived page preview